J. Kyle Anderson, MD

Associate Professor, Department of Urology

J. Kyle Anderson

Contact Info


Administrative Assistant Name
Casey Pratt

Administrative Phone

Administrative Email

Administrative Fax Number

Additional Locations

Clinic Sites

  • Institute for Prostate and Urologic Cancers

Associate Professor, Department of Urology

Surgical Service Line Chief


University of Minnesota Medical School, Minneapolis, MN

University of Minnesota, Minneapolis, MN (Urology)

University of Texas Southwestern Medical School, Dallas, TX (Endourology and Laparoscopy)


Dr. Kyle Anderson is interested in a variety of urologic conditions, including laparoscopic treatment of abnormalities including kidney cancer, ureteral pelvic junction obstruction, prostate cancer, adrenal abnormalities. He also specializes in minimally invasive thermotherapy for kidney cancer and kidney stone disease.

When he’s not in clinic, Anderson is an associate professor of urologic surgery at the University of Minnesota Medical School. His research focuses on the use of thermotherapy (cryotherapy and radiofrequency ablation) for the treatment of kidney cancer.


  • Hematuria (blood in urine)
  • Kidney stones
  • Polycystic kidney disease
  • Kidney cancer
  • Prostate cancer
  • Ureteral cancer
  • Ureteral pelvic junction obstruction
  • Ureteral obstruction

Awards & Recognition

  • Minnesota Monthly "Best Doctors" (2014)
  • Mpls.St.Paul Magazine "Top Doctor" (2015)



  • Young S, Golzarian J, Anderson JK. Thermal Ablation of T1a Renal Cell Carcinoma: The Clinical Evidence. Semin Intervent Radiol. 2019 Dec.
  • Sathianathen NJ, Krishna S, Anderson JK, Weight CJ, Gupta S, Konety BR, Griffith TS. The current status of immunobased therapies for metastatic renal-cell carcinoma. Immunotargets Ther. 2017 Dec.
  • Mandalapu RS, Remzi M, de Reijke TM, Margulis V, Palou J, Kapoor A, Yossepowitch O, Coleman J, Traxer O, Anderson JK, Catto J, de la Rosette J, O'Brien T, Zlotta A, Matin SF. Update of the ICUD-SIU consultation on upper tract urothelial carcinoma 2016: treatment of low-risk upper tract urothelial carcinoma. World J Urol. 2017 Mar.
  • Zabell JR, Larson G, Koffel J, Li D, Anderson JK, Weight CJ. Use of the Modification of Diet in Renal Disease Equation for Estimating Glomerular Filtration Rate in the Urologic Literature. J Endourol. 2016 Aug.
  • McAdams S, Sweet RM, Anderson JK. Operating Endoscopically with “Two Hands” to Remove Calcified Permanent Suture After Pyeloplasty. J Endourol Case Rep. 2016 Jan.
  • Rostambeigi N, Goldfarb R, Hunter DW, Anderson JK. Fibromuscular Dysplasia in a Normotensive Patient Presented with Renal Infarct: Case Report and Endovascular Technique. Vasc Endovascular Surg. 2015 Oct.
  • Kumar N, Crocker T, Smith T, Pow-Sang J, Spiess PE, Egan K, Quinn G, Schell M, Sebti S, Kazi A, Chuang T, Salup R, Helal M, Zagaja G, Trabulsi E, McLarty J, Fazili T, Williams CR, Schreiber F, Slaton J, Anderson JK. Challenges and potential solutions to meeting accrual goals in a Phase II chemoprevention trial for prostate cancer. Contemp Clin Trials. 2012 Mar.
  • Lucas SM, Sundaram CP, Wolf JS Jr, Leveillee RJ, Bird VG, Aziz M, Pautler SE, Luke P, Erdeljan P, Baldwin DD, Ebrahimi K, Nadler RB, Rebuck D, Thomas R, Lee BR, Boylu U, Figenshau RS, Munver R, Averch TD, Gayed B, Shalhav AL, Gundeti MS, Castle EP, Anderson JK, Duffey BG, Landman J, Okhunov Z, Wong C, Strom KH. Factors that impact the outcome of minimally invasive pyeloplasty: results of the Multi-institutional Laparoscopic and Robotic Pyeloplasty Collaborative Group. J Urol. 2012 Feb.
  • Duffey B, Nguyen V, Lund E, Koopmeiners JS, Hulbert J, Anderson JK. Intermediate-term outcomes after renal cryoablation: results of a multi-institutional study. J Endourol. 2012 Jan.
  • Anderson JK, Alanee S, Lindgren B, Slaton J. The risk of bladder cancer in patients diagnosed with other primary neoplasms: Analysis of the SEER database. Urol Oncol. 2011 Jul 22.


Board Certifications

American Board of Urology